Follow
Richard J Jones
Richard J Jones
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
L Luznik, PV O'Donnell, HJ Symons, AR Chen, MS Leffell, M Zahurak, ...
Biology of Blood and Marrow Transplantation 14 (6), 641-650, 2008
18692008
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1721*2021
Genocide: A comprehensive introduction
A Jones
Routledge, 2016
11942016
Venoocclusive disease of the liver following bone marrow transplantation
RJ Jones, KSK Lee, WE Beschorner, VG Vogel, LB Grochow, HG Braine, ...
Transplantation 44 (6), 778-783, 1987
10821987
Characterization of clonogenic multiple myeloma cells
W Matsui, CA Huff, Q Wang, MT Malehorn, J Barber, Y Tanhehco, ...
Blood 103 (6), 2332-2336, 2004
10292004
Cyclophosphamide and cancer: golden anniversary
A Emadi, RJ Jones, RA Brodsky
Nature reviews Clinical oncology 6 (11), 638-647, 2009
10082009
Decreased erythropoietin response in patients with the anemia of cancer
CB Miller, RJ Jones, S Piantadosi, MD Abeloff, JL Spivak
New England Journal of Medicine 322 (24), 1689-1692, 1990
9421990
Inhibition of apoptosis during development of colorectal cancer
A Bedi, PJ Pasricha, AJ Akhtar, JP Barber, GC Bedi, FM Giardiello, ...
Cancer research 55 (9), 1811-1816, 1995
7881995
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
A Bedi, BA Zehnbauer, JP Barber, SJ Sharkis, RJ Jones
Blood 83 (8), 2038-2044, 1994
7031994
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
W Matsui, Q Wang, JP Barber, S Brennan, BD Smith, I Borrello, I McNiece, ...
Cancer research 68 (1), 190-197, 2008
6832008
Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells
RJ Jones, JE Wagner, P Celano, MS Zicha, SJ Sharkis
Nature 347 (6289), 188-189, 1990
5421990
The North American regional climate change assessment program: overview of phase I results
LO Mearns, R Arritt, S Biner, MS Bukovsky, S McGinnis, S Sain, D Caya, ...
Bulletin of the American Meteorological Society 93 (9), 1337-1362, 2012
5292012
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'donnell, L Luznik, RJ Jones, GB Vogelsang, MS Leffell, M Phelps, ...
Biology of Blood and Marrow Transplantation 8 (7), 377-386, 2002
5072002
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
LB Grochow, RJ Jones, RB Brundrett, HG Braine, TL Chen, R Saral, ...
Cancer chemotherapy and pharmacology 25, 55-61, 1989
4841989
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents
A Bedi, JP Barber, GC Bedi, WS El-Deiry, D Sidransky, MS Vala, ...
4821995
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol
EK Rowinsky, RC Donehower, RJ Jones, RW Tucker
Cancer research 48 (14), 4093-4100, 1988
4791988
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaņos-Meade, M Zahurak, AR Chen, BD Smith, R Brodsky, ...
Blood, The Journal of the American Society of Hematology 115 (16), 3224-3230, 2010
4532010
Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
RJ Jones, RF Ambinder, S Piantadosi, GW Santos
4441991
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
J Bolaņos-Meade, EJ Fuchs, L Luznik, SM Lanzkron, CJ Gamper, ...
Blood, The Journal of the American Society of Hematology 120 (22), 4285-4291, 2012
4402012
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
434*2021
The system can't perform the operation now. Try again later.
Articles 1–20